Enhancer ID: | E_02_0795 |
Species: | mouse |
Position : | chr9:88325101-88326201 |
Biosample name: | |
Experiment class : | Low throughput |
Enhancer type: | Enhancer |
Disease: | Hepatic fibrosis |
Pubmed ID: | 28667437 |
Enhancer experiment: | Luciferase Reporter Assay |
Enhancer experiment description: | The measured luciferase activity noticeably decreased between F1- and F2-Luc constructs, suggesting that F1-Luc construct contains a potential enhancer sequence, which spans approximately 1000 bp (?2069 to ?996 bp) and is absent in the shorter F2-Luc construct. |
Target gene : | Nt5e(CALJA,CD73,E5NT,NT,NT5,NTE,eN,eNT) |
Strong evidence: | -- |
Less strong evidence: | Luciferase Reporter Assay,PCR |
Target gene experiment description: | Luciferase activity as_x0002_says showed that the ENH1074-F5-Luc construct containing the full putative Enhancer (-2069 to -996 bp) sequence has the ability to enhance the luciferase activity of the identified putative mouse Nt5e promoter. |
TF name : | Elf2(2610036A20Rik,A230104O07Rik,AW111824,BB183398,EU32,NERF,NERF-1A,NERF-1B,NERF-2) |
TF experiment: | Luciferase Reporter Assay |
TF experiment description: | We found that mutation of Elf2 responsive element alone was sufficient to significantly increase the F5-Luc construct luciferase activity (F5-Luc, 11.79 1.41 vs. mut Elf2-F5-Luc,20.48 2.96, **p < 0.01).These data indicate that repression of mouse Nt5e promoter activity is likely mediated by transcription factor(s) acting at the identified Elf2 site in NIH3T3 fibroblasts. |
Enhancer function : | -- |
Enhancer function experiment: | -- |
Enhancer function experiment description: |
-- |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|---|---|---|
Elf2 | Angiopoietin receptor Tie2-mediated signaling | pid | 50 |
Elf2 | PDGF signaling pathway | panther | 113 |